June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Rami Manochakian: Big News Released by Summit Therapeutics on HARMONi Phase III Global Trial at ASCO 2025
Jun 1, 2025, 08:04

Rami Manochakian: Big News Released by Summit Therapeutics on HARMONi Phase III Global Trial at ASCO 2025

Rami Manochakian, Vice President of the North American Neuroendocrine Tumor Society, shared a post on X:

“Hot Off The Press
Big News Release by Summit Therapeutics in time with ASCO 25.
Results from the HARMONi Phase III global trial evaluating:
Ivonescimab + Chemo vs Chemo in patients with advanced EGFR+ NSCLC after progression on 3rd gen TKI:
Statistically significant and clinically meaningful Improvement in progression-free survival.
PFS HR: 0.52
OS positive trend: HR 0.79″

Summit Therapeutics

Read more about HARMONi Study.

More posts featuring Rami Manochakian on OncoDaily.